Status:
RECRUITING
Measles and BCG Vaccines for Mother and Child
Lead Sponsor:
Bandim Health Project
Collaborating Sponsors:
The University of Western Australia
Université Libre de Bruxelles
Conditions:
Vaccine Preventable Disease
Measles
Eligibility:
FEMALE
15-35 years
Phase:
PHASE4
Brief Summary
In Africa, the mortality from infectious diseases remains high. The investigators have discovered that live vaccines such as the BCG vaccine against tuberculosis and the measles vaccine can strengthen...
Detailed Description
OBJECTIVES The investigators aim to study the effects of providing measles vaccine (MV) or Bacille Calmette-Guérin vaccine (BCG) to women of fertile age, prior to pregnancy, and to study the added eff...
Eligibility Criteria
Inclusion
- Female women in the fertile age
- Non-pregnant
- HIV-negative
- Living in the BHP HDSS study area
- Delivered a child that has reached 12 months of age
- Currently not using contraceptives.
Exclusion
- Positive pregnancy test
- Positive HIV test
- Tuberculosis (previous or current)
- Immunodeficiency
- Cancer within the last 2 years
- Mid-upper-arm-circumference\<200
- Acute ongoing infection
Key Trial Info
Start Date :
May 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT04899765
Start Date
May 20 2021
End Date
December 31 2027
Last Update
January 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Bissau, Bissau Codex, Guinea-Bissau, 1004